Skip Nav Destination
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS|
August 21, 2025
Allo-HCT in Hodgkin lymphoma after CPI Free
CME
Blood (2025) 146 (8): 1030.
Connected Content
A related article has been published:
Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
Citation
Allo-HCT in Hodgkin lymphoma after CPI. Blood 2025; 146 (8): 1030. doi: https://doi.org/10.1182/blood.2025030720
Download citation file:
August 21 2025
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal